-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Protease Inhibitors in Development
- A Clinical Overview of Brecanavir (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health - Brecanavir Shows Good Cross-Resistance Profile (August 17, 2006)
In XVI International AIDS Conference - Brecanavir Shows Favorable Pharmacokinetics When Combined With Select PIs in Double-Boosted Regimens (August 15, 2006)
In XVI International AIDS Conference - New Protease Inhibitor Brecanavir Shown to Be Safe and Effective in Small Study (December 16, 2005)
In The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy - Safety and Pharmacokinetic Data for 640385, a New Protease Inhibitor in Development (February 24, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Protease Inhibitors in Development
An overview from Edwin DeJesus, M.D.
From The Body PRO
  |